Clave exits Abanzamed with an equity multiple of 4.25x.

by CLAVE

Since its incorporation, Abanzamed has developed a pipeline of various fixation systems for surgeries, initially focused on the knee and now diversifying into ankle and shoulder, based on a patented t...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Ares Raises $12.7 Billion to Invest in A...

by Ares Management Corporation

Investors representing approximately $4.0 billion of commitments in Pa...

Photos Stream